Patent · US Active

Tryptophan hydroxylase inhibitors

US8629156B2 · kind B2 · utility

2Cited by

36References

9Claims

0Family size

Assignee

LEXICON PHARMACEUTICALS, INC. · US

Inventors

Arokiasamy Devasagayaraj · Plainsboro, US
Haihong Jin · Manalapan, US
Qingyun Liu · North Wales, US
Brett Marinelli · Hillsborough Township, US
Lakshama Samala · Princeton, US
Zhi-Cai Shi · Monmouth Junction, US
Ashok Tunoori · Princeton, US
Ying Wang · Chengdu, CN
Wenxue Wu · Princeton Junction, US
Chengmin Zhang · Florham Park, US
Haiming Zhang · Pennington, US

Key dates

Filing date	Nov 7, 2011
Grant date	Jan 14, 2014
Priority date	—
Expiry date	Nov 7, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2601/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of formulae I and II are disclosed, as well as compositions comprising them and methods of their use to treat, prevent and manage serotonin-mediated diseases and disorders:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.